FDA Approves First Gene Therapy to Treat Adults with Hemophilia B – FDA.gov

Posted: November 24, 2022 at 12:21 am

  1. FDA Approves First Gene Therapy to Treat Adults with Hemophilia B  FDA.gov
  2. Gene therapy at $3.5m a dose approved for US adults with hemophilia B  The Guardian
  3. FDA approves gene therapy for hemophilia  Axios
  4. FDA Approves Hemgenix, First Gene Therapy to Treat Adults with Hemophilia B  Everyday Health
  5. Costing $3.5M, first hemophilia B gene therapy wins FDA approval  FiercePharma
  6. View Full Coverage on Google News

Go here to read the rest:
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B - FDA.gov

Related Posts